The European Alliance of Associations for Rheumatology (EULAR) guidelines for the management of large vessel vasculitis recommends regular follow-up and monitoring of GCA disease activity based on symptoms, clinical findings, and systemic inflammation measured by erythrocyte sedimentation rate (ESR) and CRP levels (15). This evidence concerns the gene CRP and temporal arteritis.